» Articles » PMID: 28633877

Epithelial Proteome Profiling Suggests the Essential Role of Interferon-inducible Proteins in Patients with Allergic Rhinitis

Overview
Date 2017 Jun 22
PMID 28633877
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Seasonal allergic rhinitis (SAR) caused by intermittent exposure to seasonal pollen causes itching, nasal congestion, and repeated sneezing, with profound effects on quality of life, work productivity, and school performance. Although both the genotype and environmental factors can contribute to the immunologic basis of allergic reactions, the molecular underpinnings associated with the pathogenesis of allergic rhinitis are not entirely clear.

Methods: To address these questions, nasal epithelial brushings were collected from 29 patients with SAR and 31 control subjects during and after the pollen season. We then implemented an orbitrap-based, bottom-up, label-free quantitative proteomics approach, followed by multivariate analyses to identify differentially abundant (DA) proteins among the 4 sample groups.

Results: We identified a total of 133 DA proteins for which the most significantly overrepresented functional category was found to be interferon 1 signaling. Two proteins, cystatin 1 and myeloblastin, the former of which protects against protease activity of allergens and the latter with a role in epithelial barrier function, were DA in patients with SAR and control subjects, irrespective of season. Moreover, interferon-inducible protein with tetratricopeptide repeats 1, cystatin 1, and interferon-inducible protein with tetratricopeptide repeats 3 were found to be differentially regulated between patients with SAR and control subjects, with inverse abundance dynamics during the transition from fall to spring.

Conclusion: We identified type 1 interferon-regulated proteins as biomarkers in patients with SAR, potentially playing an important role in its pathogenesis. Moreover, when compared with patients with SAR, healthy subjects exhibit an antagonistic proteomic response across seasons, which might prove to be a therapeutic target for disease prevention.

Citing Articles

IL-1β and iNOS can drive the asthmatic comorbidities and decrease of lung function in perennial allergic rhinitis children.

Han M, Kim S, Oh I, Kim Y, Lee J Allergy Asthma Clin Immunol. 2024; 20(1):1.

PMID: 38167134 PMC: 10763256. DOI: 10.1186/s13223-023-00867-3.


Genes related to allergen exposure in allergic rhinitis: a gene-chip-based study in a mouse model.

Wang M, Li Y, Yang J, Wang X, Zhang L BMC Med Genomics. 2022; 15(1):243.

PMID: 36434595 PMC: 9701046. DOI: 10.1186/s12920-022-01389-4.


Current Insights on the Impact of Proteomics in Respiratory Allergies.

Vizuet-de-Rueda J, Montero-Vargas J, Galvan-Morales M, Porras-Gutierrez-de-Velasco R, Teran L Int J Mol Sci. 2022; 23(10).

PMID: 35628512 PMC: 9144092. DOI: 10.3390/ijms23105703.


DNA methylation biomarkers in asthma and rhinitis: Are we there yet?.

Legaki E, Arsenis C, Taka S, Papadopoulos N Clin Transl Allergy. 2022; 12(3):e12131.

PMID: 35344303 PMC: 8967268. DOI: 10.1002/clt2.12131.


Bet v 1 triggers antiviral-type immune signalling in birch-pollen-allergic individuals.

Wisgrill L, Fyhrquist N, Ndika J, Paalanen L, Berger A, Laatikainen T Clin Exp Allergy. 2022; 52(8):929-941.

PMID: 35147263 PMC: 9540660. DOI: 10.1111/cea.14108.